Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1220
+0.0065 (5.63%)
Sep 25, 2026, 5:29 PM CET

Prostatype Genomics AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6818741148135
Market Cap Growth
96.34%-76.14%555.78%-76.58%-64.07%-28.46%
Enterprise Value
68573030110
Last Close Price
0.120.3011.1095.00704.882972.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
84.8829.89373.998.3770.9513487.32
PB Ratio
10.440.672.220.461.853.76
P/TBV Ratio
-0.732.420.461.853.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
84.408.12365.020.2443.9110969.69

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.200.000.470.030.04
Net Debt / Equity Ratio
-0.06-0.14-0.280.36-0.41-0.53
Net Debt / EBITDA Ratio
0.010.100.24-0.230.371.23
Net Debt / FCF Ratio
0.020.160.21-0.310.381.19
Asset Turnover
0.020.010.000.030.020
Inventory Turnover
139.18240.44150.03103.0274.1129.43
Quick Ratio
0.040.401.240.163.156.12
Current Ratio
0.040.441.391.063.276.29
Return on Equity (ROE)
-176.16%-148.35%-141.21%-163.05%-93.74%-48.69%
Return on Assets (ROA)
-55.91%-52.43%-56.00%-61.19%-50.40%-26.31%
Return on Capital Employed (ROCE)
-572.10%-146.80%-122.10%-158.60%-107.80%-42.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-55.47%-250.63%-55.16%-365.11%-60.02%-11.59%
FCF Yield
-30.67%-135.49%-60.46%-257.41%-57.15%-11.92%
Buyback Yield / Dilution
-477.40%-2294.78%-1645.51%-343.99%-28.75%-